Latest period
$6.76M
YoY change
-25.0%
5Y CAGR
-16.2%
Peak year (2013)
$82.09M
Latest annual
$7.47M
Total Liabilities history chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: $7.47M
Total Liabilities growth chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: -25.0%
Total Liabilities history table for SELLAS Life Sciences Group (SLS) from 2006 to 2025
| 2025 | $7.47M | -25.0% | −$2.49M | ||
| 2024 | $9.97M | -29.8% | −$4.23M | ||
| 2023 | $14.20M | -11.8% | −$1.90M | ||
| 2022 | $16.09M | +164.7% | +$10.01M | ||
| 2021 | $6.08M | -66.4% | −$12.01M | ||
| 2020 | $18.09M | +72.0% | +$7.57M | ||
| 2019 | $10.52M | -9.9% | −$1.15M | ||
| 2018 | $11.67M | -62.9% | −$19.79M | ||
| 2017 | $31.46M | -15.3% | −$5.70M | ||
| 2016 | $37.15M | -45.9% | −$31.48M | ||
| 2015 | $68.63M | +58.0% | +$25.20M | ||
| 2014 | $43.43M | -47.1% | −$38.66M | ||
| 2013 | $82.09M | +201.5% | +$54.86M | ||
| 2012 | $27.23M | +30.6% | +$6.37M | ||
| 2011 | $20.86M | +313.3% | +$15.81M | ||
| 2010 | $5.05M | -8.4% | −$465.00K | ||
| 2009 | $5.51M | +296.2% | +$4.12M | ||
| 2008 | $1.39M | +5.1% | +$67.00K | ||
| 2007 | $1.32M | — | +$1.32M | ||
| 2006 | $0.00 | — | — |
- 2025$7.47M-25.0%
- 2024$9.97M-29.8%
- 2023$14.20M-11.8%
- 2022$16.09M+164.7%
- 2021$6.08M-66.4%
- 2020$18.09M+72.0%
- 2019$10.52M-9.9%
- 2018$11.67M-62.9%
- 2017$31.46M-15.3%
- 2016$37.15M-45.9%
- 2015$68.63M+58.0%
- 2014$43.43M-47.1%
- 2013$82.09M+201.5%
- 2012$27.23M+30.6%
- 2011$20.86M+313.3%
- 2010$5.05M-8.4%
- 2009$5.51M+296.2%
- 2008$1.39M+5.1%
- 2007$1.32M—
- 2006$0.00—
Total Liabilities values are taken from SELLAS Life Sciences Group's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's latest reported total liabilities is $6.76M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for SELLAS Life Sciences Group (SLS) came in at $7.47M – declined 25.0% year-over-year.
Over 2020–2025 (5 years), SELLAS Life Sciences Group total liabilities expanded at a -16.2% compound annual rate, with a net decline across the window.
Across the available history, total liabilities reached its high of $82.09M in 2013 and its low of $0.00 in 2006.
SELLAS Life Sciences Group Total Liabilities by Year
SELLAS Life Sciences Group Total Liabilities 2025: $7.47M
In 2025, SELLAS Life Sciences Group reported total liabilities of $7.47M, declined 25.0% below 2024.
SELLAS Life Sciences Group Total Liabilities 2024: $9.97M
SELLAS Life Sciences Group total liabilities in 2024 was $9.97M, declined 29.8% below 2023.
SELLAS Life Sciences Group Total Liabilities 2023: $14.20M
2023's total liabilities for SELLAS Life Sciences Group came in at $14.20M, declined 11.8% below 2022.
SELLAS Life Sciences Group Total Liabilities 2022: $16.09M
SELLAS Life Sciences Group posted total liabilities of $16.09M in 2022, surged 164.7% from 2021.
SELLAS Life Sciences Group Total Liabilities 2021: $6.08M
SELLAS Life Sciences Group total liabilities in 2021 was $6.08M.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by Total Liabilities
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation